We did not observe any adverse phenotypic associations (P < 1 × 10−4), including coronary artery or cardiovascular disease, in individuals with loss of MAP3K15 (“ptv,” “ptv5pcnt,” and “rec” collapsing models) (table S26). Here, MAP3K15 is linked to cardiovascular disorder.